____________________________________________________________
Programme
____________________________________________________________
| Time | Session/Presenter/Topic |
19:00 - 20:30 | Welcome Reception - Composers Suite |
| Time | Session/Presenter/Topic |
08:00 - 09:00 09:00 - 09:10 09:10 -11:00 | Registration and Refreshments - Lloyd Suite Welcome Screening Programmes Session 1 Chairs: Parth Narendran & Lucy Chambers The Italian Experience - Emanuele Bosi, Milan (09:10 - 09:30) The US Experience - Marian Rewers, Denver, Colorado (09:30 - 09:50) ELSA - Lauren Quinn, Birmingham (09:50 - 10:10) T1DRA - Kathleen Gillespie, Bristol (10:10 - 10:30) Panel discussion on implementing screening in the UK - All speakers, Primary Care Diabetes Society (10:30 - 11:00) |
11:00 - 11:30 | COFFEE BREAK |
11:30 - 12:40 | How can genetic analysis support the identification of children and adults with pre-symptomatic T1D? – Richard Oram, Exeter (11:30 - 11:50) Research studies into monitoring of pre-T1D Chairs: Renuka Dias & Emily Simms Current UK research Monitoring studies in Children - Loredana Marcovecchio, Cambridge (11:50 - 12:10) Current UK Research Monitoring studies in Adults - Anna Long, Bristol (12:10 - 12:40) |
12:40 - 13:40 | LUNCH |
13:40 - 15:10 | Optimising Ab assays for T1D screening - Alex Richter, Birmingham (13:40 - 14:00) Managing pre-symptomatic T1D in UK clinical practice Chairs: Fiona Campbell & Danijela Tatovic Monitoring children in UK clinical practice and the UK Ab Registry - Rachel Besser, Oxford (14:00 - 14:20) Accurate disease classification and monitoring of pre-symptomatic T1D in adults - Nick Thomas, Exeter (14:20 - 14:40) Panel Discussion with Marc Atkin and Fulya Mehta, led by Fiona Campbell and Danijela Tatovic (14:40 - 15:10) |
15:10 - 15:30 | COFFEE BREAK |
15:30 - 16:30 | Parallel 'meet the expert' sessions in breakout rooms a) Running a pre-symptomatic T1D service in paediatrics - Renuka Dias, Rachel Besser and Emily Simms - Lloyd Suite b) Running a pre-symptomatic T1D service in adults - Nick Thomas, Parth Narendran and Kimber Simmons - Fry Suite |
16:30 | CLOSE |
19:00 - 22:00 | Conference Dinner - Fry Suite After Dinner Speaker - Partha Kar |
| Time | Session/Presenter/Topic |
08:00 - 09:00 09:00 - 10:50 | Registration and Refreshments - Fry Lounge Psychosocial Impact Chair: Olga Boiko The psychological impact of early detection T1D, a summary of evidence so far - Olga Boiko, Birmingham (09:00 - 09:20) Prediction and prevention of rheumatoid arthritis: Perspectives of people at risk, patients, and healthcare professionals - Marie Falahee, University of Birmingham (09:20 - 09:40) Living with Chronic Uncertainty, examples from Cystic Fibrosis (CFSPID) - Felicity Boardman, University of Warwick (09:40 - 10:00) A patient experience of screening - 10 mins for family and adult (ELSA, T1DRA) (10:00 - 10:30) Panel discussion with all speakers (10:30 - 10:50) |
10:50 - 11:20 | COFFEE BREAK |
11:20 - 13:00 |
Disease Modifying Therapy for T1D Chairs: Tim Tree & Colin Dayan Lessons from MS - Gavin Giovannoni, London (11:20 - 11:40) The US Experience - Kimber Simmons, Denver (11:40 - 12:00) The UK Experience - Renuka Dias, Birmingham and Neil Wright, Sheffield (12:00 - 12:20) Navigating the practicalities of accessing and delivering a 14-day therapy - Phil Newland Jones, Southampton (12:20 - 12:40) Panel Discussion (12:40 - 13:00) |
13:00 - 14:00 | LUNCH |
14:00 - 15:00 | The Future Chairs: Susan Wong & Rachel Connor Pipeline of DMTs in T1D - Emily Simms (14:00 - 14:30) The T1DRC, Platform trials and the future - Colin Dayan, Cardiff (14:30 - 15:00) |
15:00 | CLOSING REMARKS |
Disclaimer:
Sanofi have had no involvement in the agenda/speaker selection or the organisation of the meeting and are involved as an exhibitor only.